{"hands_on_practices": [{"introduction": "The growth of solid tumors beyond a minimal size is critically dependent on angiogenesis, the formation of new blood vessels. This process is initiated by pro-angiogenic signals, such as Vascular Endothelial Growth Factor (VEGF), secreted by the tumor. This first practice challenges you to model the fundamental biophysics of this signaling event by applying the law of mass action to the binding of VEGF to its receptor on endothelial cells. By deriving receptor occupancy as a function of ligand concentration, you will gain a quantitative understanding of how cells translate an external chemical signal into a downstream response, a core concept in cell biology and pharmacology [@problem_id:2967628].", "problem": "Angiogenesis in tumors is driven by endothelial cell responses to Vascular Endothelial Growth Factor (VEGF) signaling through the Vascular Endothelial Growth Factor Receptor (VEGFR). Consider monovalent binding of VEGF ligand to VEGFR on an endothelial cell surface at equilibrium. Use the law of mass action and the definition of the dissociation constant to model receptor occupancy and signaling. Assume a fixed receptor density so that the total receptor concentration is constant, and that ligand is in sufficient excess that free ligand is approximately equal to total ligand.\n\nStart from the following fundamental base:\n- The law of mass action for a single-site receptor: for the reaction $R + L \\rightleftharpoons RL$, the dissociation constant is $K_d = \\frac{[R][L]}{[RL]}$ at equilibrium.\n- Receptor conservation: $R_{\\text{tot}} = [R] + [RL]$.\n- Define the receptor occupancy as the fraction of receptors bound by ligand: $\\theta = \\frac{[RL]}{R_{\\text{tot}}}$.\n- Assume that downstream signaling output is limited by receptor occupancy so that signaling strength $S$ is proportional to occupancy: $S = \\alpha \\,\\theta$, where $\\alpha$ is a constant of proportionality that does not depend on ligand concentration.\n\nLet the ligand concentration span from $[L] = 0.1\\,K_d$ to $[L] = 10\\,K_d$. Using only the above fundamental definitions and assumptions, derive an expression for $\\theta([L])$ and use it to compute the fold-change in signaling strength between $[L] = 10\\,K_d$ and $[L] = 0.1\\,K_d$, defined as $F = \\frac{S(10\\,K_d)}{S(0.1\\,K_d)}$. Express your final answer as a single dimensionless number. No rounding is required.", "solution": "We are given a single-site receptor–ligand equilibrium $R + L \\rightleftharpoons RL$ with dissociation constant defined by the law of mass action:\n$$\nK_d = \\frac{[R][L]}{[RL]}.\n$$\nWe also have receptor conservation:\n$$\nR_{\\text{tot}} = [R] + [RL].\n$$\nWe wish to derive the receptor occupancy $\\theta$, defined as\n$$\n\\theta = \\frac{[RL]}{R_{\\text{tot}}}.\n$$\nWe are told that ligand is in sufficient excess such that the free ligand concentration is approximately equal to the total ligand concentration, so we can treat $[L]$ as a fixed parameter independent of receptor binding. Solve the equilibrium for $[RL]$ in terms of $[L]$, $K_d$, and $R_{\\text{tot}}$.\n\nFrom the definition of $K_d$,\n$$\n[RL] = \\frac{[R][L]}{K_d}.\n$$\nUsing receptor conservation to eliminate $[R] = R_{\\text{tot}} - [RL]$, we get\n$$\n[RL] = \\frac{(R_{\\text{tot}} - [RL])[L]}{K_d}.\n$$\nRearrange to solve for $[RL]$:\n$$\n[RL] = \\frac{R_{\\text{tot}}[L]}{K_d} - \\frac{[RL][L]}{K_d}\n\\quad\\Rightarrow\\quad\n[RL]\\left(1 + \\frac{[L]}{K_d}\\right) = \\frac{R_{\\text{tot}}[L]}{K_d}.\n$$\nHence,\n$$\n[RL] = \\frac{R_{\\text{tot}}[L]}{K_d + [L]}.\n$$\nTherefore the occupancy is\n$$\n\\theta = \\frac{[RL]}{R_{\\text{tot}}} = \\frac{[L]}{K_d + [L]}.\n$$\n\nThe signaling strength is proportional to occupancy:\n$$\nS([L]) = \\alpha\\,\\theta([L]) = \\alpha\\,\\frac{[L]}{K_d + [L]}.\n$$\nThe fold-change between $[L] = 10\\,K_d$ and $[L] = 0.1\\,K_d$ is\n$$\nF = \\frac{S(10\\,K_d)}{S(0.1\\,K_d)} = \\frac{\\alpha\\,\\frac{10\\,K_d}{K_d + 10\\,K_d}}{\\alpha\\,\\frac{0.1\\,K_d}{K_d + 0.1\\,K_d}}.\n$$\nThe proportionality constant $\\alpha$ cancels, and $K_d$ factors cancel within each fraction:\n$$\nF = \\frac{\\frac{10}{1 + 10}}{\\frac{0.1}{1 + 0.1}} = \\frac{\\frac{10}{11}}{\\frac{0.1}{1.1}}.\n$$\nNote that $\\frac{0.1}{1.1} = \\frac{1}{11}$, so\n$$\nF = \\frac{10/11}{1/11} = 10.\n$$\nThus the fold-change in signaling strength across the ligand concentration range from $0.1\\,K_d$ to $10\\,K_d$ is exactly $10$ under the stated assumptions.", "answer": "$$\\boxed{10}$$", "id": "2967628"}, {"introduction": "For a tumor cell to metastasize, it must often undergo a profound change in its phenotype through the epithelial-to-mesenchymal transition (EMT), shedding its stationary, epithelial characteristics to adopt a migratory, mesenchymal state. This is not merely a graded change but a decisive switch governed by an underlying genetic circuit. This exercise explores the systems biology of the canonical ZEB/miR-200 mutual repression circuit, which acts as a bistable toggle switch. By analyzing the mathematical model of this circuit, you will derive the conditions for hysteresis, providing a concrete explanation for how cells can commit to and stably maintain distinct epithelial or mesenchymal fates [@problem_id:2967728].", "problem": "Epithelial-to-mesenchymal transition (EMT) is sustained by a mutually inhibitory regulatory circuit between the zinc finger E-box-binding homeobox (ZEB) transcription factors and the microRNA-200 (miR-200) family. A common coarse-grained model for such a two-node mutual repression circuit uses deterministic Hill-type regulation with first-order loss, justified by the central dogma of molecular biology and well-tested biochemical phenomenology for cooperative binding and degradation. Consider the dimensionless, symmetric form of the ZEB–miR-200 toggle switch:\n$$\n\\frac{dx}{dt} \\;=\\; \\frac{a}{1 + y^{n}} \\;-\\; x, \n\\qquad\n\\frac{dy}{dt} \\;=\\; \\frac{a}{1 + x^{n}} \\;-\\; y,\n$$\nwhere $x$ and $y$ are the dimensionless activities of ZEB and miR-200, respectively, $a$ is a dimensionless composite feedback strength proportional to the maximal production rate scaled by the effective threshold and loss rate, and $n$ is the Hill coefficient capturing cooperativity of repression. Assume time has been scaled by the common first-order loss rate and both repressors share the same effective threshold after nondimensionalization.\n\nFrom first principles of steady states, nullclines, and the onset of a saddle-node bifurcation in a symmetric mutual repression system, derive the analytic expression for the critical composite feedback strength $a_{c}(n)$ at which the system transitions from a single steady state to three steady states along the exchange-symmetric subspace $x=y$. This transition is the onset of bistability required for hysteresis between epithelial and mesenchymal states in response to slow modulation of $a$ by upstream EMT-inducing cues. Your final answer must be the closed-form expression for $a_{c}(n)$ as a function of $n$. Do not provide inequalities. No units are required.", "solution": "The ZEB–miR-200 toggle is modeled by\n$$\n\\frac{dx}{dt} \\;=\\; \\frac{a}{1 + y^{n}} \\;-\\; x, \n\\qquad\n\\frac{dy}{dt} \\;=\\; \\frac{a}{1 + x^{n}} \\;-\\; y,\n$$\nwith $a>0$ and $n \\ge 1$ representing the composite feedback strength and Hill cooperativity, respectively. The steady states satisfy\n$$\nx \\;=\\; \\frac{a}{1 + y^{n}}, \n\\qquad\ny \\;=\\; \\frac{a}{1 + x^{n}}.\n$$\nBy exchange symmetry, the onset of multiple steady states occurs on the invariant diagonal $x=y$. Let $x=y=s$ at the symmetry-respecting steady state. Then\n$$\ns \\;=\\; \\frac{a}{1 + s^{n}} \\;\\;\\Longleftrightarrow\\;\\; a \\;=\\; s\\,(1 + s^{n}).\n$$\nTo determine when this steady state undergoes a saddle-node bifurcation that creates two additional steady states (one stable and one unstable), we use the standard one-dimensional reduction on the invariant subspace or, equivalently, a fixed-point map argument. Define the nullcline function\n$$\nf(x) \\;=\\; \\frac{a}{1 + x^{n}},\n$$\nso that steady states on the diagonal satisfy $s = f(s)$ when $x=y=s$. The number of intersections between $y=f(x)$ and the line $y=x$ changes when the slope condition for tangency is met at the intersection. For the symmetric mutual repressor, the onset of bistability on the diagonal is given by the condition that the magnitude of the slope of the nullcline equals that of the diagonal at the intersection in the reduced map sense, which yields\n$$\n\\left| f'(s) \\right| \\;=\\; 1.\n$$\nCompute the derivative:\n$$\nf'(x) \\;=\\; -\\,\\frac{a\\,n\\,x^{n-1}}{(1 + x^{n})^{2}}.\n$$\nEvaluating at $x=s$ and substituting $a = s(1 + s^{n})$ from the steady-state condition gives\n$$\nf'(s) \\;=\\; -\\,\\frac{s(1 + s^{n})\\,n\\,s^{n-1}}{(1 + s^{n})^{2}}\n\\;=\\; -\\,\\frac{n\\,s^{n}}{1 + s^{n}}.\n$$\nThe bifurcation condition $\\left| f'(s) \\right|=1$ thus becomes\n$$\n\\frac{n\\,s^{n}}{1 + s^{n}} \\;=\\; 1 \n\\;\\;\\Longleftrightarrow\\;\\; n\\,s^{n} \\;=\\; 1 + s^{n}\n\\;\\;\\Longleftrightarrow\\;\\; (n-1)\\,s^{n} \\;=\\; 1.\n$$\nHence\n$$\ns^{n} \\;=\\; \\frac{1}{n-1}, \n\\qquad\ns \\;=\\; (n-1)^{-1/n},\n$$\nwhich requires $n>1$ to yield a positive finite solution. Substituting this $s$ back into $a = s(1 + s^{n})$ gives the critical composite feedback strength\n$$\na_{c}(n) \\;=\\; s\\!\\left(1 + s^{n}\\right) \\;=\\; (n-1)^{-1/n}\\!\\left(1 + \\frac{1}{n-1}\\right)\n\\;=\\; (n-1)^{-1/n}\\,\\frac{n}{n-1}.\n$$\nCollecting factors,\n$$\na_{c}(n) \\;=\\; \\frac{n}{(n-1)^{\\,1 + 1/n}}.\n$$\nThis expression is the exact analytic threshold separating monostability from bistability (and thus enabling hysteresis under slow variation of $a$) for the symmetric, dimensionless ZEB–miR-200 toggle. It applies for $n>1$; for $n\\le 1$ the right-hand side diverges, consistent with the absence of bistability without cooperativity.", "answer": "$$\\boxed{\\frac{n}{(n-1)^{1+1/n}}}$$", "id": "2967728"}, {"introduction": "After a cell has been activated by signals and has switched its internal state via EMT, it must acquire the functional tools to invade surrounding tissues and intravasate into blood vessels. A key part of this invasive toolkit is the family of matrix metalloproteinases (MMPs), enzymes that degrade the extracellular matrix. This final practice moves from mathematical modeling to experimental design, challenging you to think like a bench scientist. You will critically evaluate different experimental protocols to design a rigorous experiment that not only measures MMP activity but also establishes a causal link between this activity and the invasive capacity of angiogenic cells, a crucial skill for validating biological hypotheses [@problem_id:2967648].", "problem": "You are investigating how matrix metalloproteinase (MMP) activity differs between angiogenic and quiescent endothelial cell populations and how these differences relate to invasion capacity. Consider the following foundational facts and definitions as the starting point for your design and interpretation.\n\nMatrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that degrade extracellular matrix proteins. The gelatinases, MMP-2 and MMP-9, cleave denatured collagen (gelatin) and exist as latent proenzymes that require activation to become catalytically competent. Gelatin zymography resolves enzymes by sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) in the presence of gelatin co-polymerized in the gel; after removal of sodium dodecyl sulfate and renaturation, gelatinases digest the substrate during incubation in a buffer supplying divalent cations, producing clear bands on a stained background. Invasion through extracellular matrix barriers (for example, in a transwell Matrigel assay) requires proteolysis and is often MMP-dependent. Chelators of divalent cations such as ethylenediaminetetraacetic acid (EDTA) or 1,10-phenanthroline inhibit metalloproteinases by removing the catalytic zinc ion.\n\nYou culture human endothelial cells under two conditions: an angiogenic program induced by vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), and a quiescent state achieved by contact inhibition and serum withdrawal. You must choose an experimental design and interpretation that rigorously quantifies gelatinase activity in each population, controls for confounders, and logically links the enzymatic activity to invasion capacity.\n\nWhich of the following options is the most scientifically sound and establishes a mechanistic relationship between MMP activity and invasion in this context?\n\nA. Collect conditioned media for $16\\,\\mathrm{h}$ in serum-free medium from equal numbers of angiogenic (VEGF/bFGF-stimulated) and quiescent endothelial cells, verify equal total protein per lane by bicinchoninic acid assay, and load equal amounts without boiling or reducing agents onto an SDS-PAGE gel containing $0.1\\%$ gelatin. After electrophoresis, renature in $2.5\\%$ Triton X-100 and develop in a buffer containing $10\\,\\mathrm{mM}$ calcium chloride and $50\\,\\mathrm{mM}$ Tris, pH $7.5$, without chelators. Include lanes developed with $5\\,\\mathrm{mM}$ EDTA as negative controls and recombinant MMP-2/MMP-9 standards to assign the pro- and active bands (approximately $72/62\\,\\mathrm{kDa}$ for MMP-2 and $92/82\\,\\mathrm{kDa}$ for MMP-9). Perform densitometry of clear bands and report that angiogenic cells exhibit approximately $3$-fold higher active MMP-2 and $2$-fold higher active MMP-9 activity relative to quiescent cells. In parallel Matrigel transwell assays (pore size $8\\,\\mu\\mathrm{m}$) normalized to input cell number, observe a proportional increase in invasion for angiogenic cells that is suppressed by $50\\,\\mu\\mathrm{M}$ 1,10-phenanthroline and by small interfering RNA (siRNA) targeting MMP-2. Conclude that increased gelatinase activity causally contributes to the elevated invasion of angiogenic endothelial cells.\n\nB. Boil all conditioned media samples for $5\\,\\mathrm{min}$ with $5\\%$ $\\beta$-mercaptoethanol before loading on reducing SDS-PAGE with co-polymerized gelatin. Develop the gel in buffer containing $10\\,\\mathrm{mM}$ EDTA to protect metalloproteinases from autolysis. Quantify the intensity of Coomassie-stained protein bands (darker bands) as a measure of activity without normalizing for cell number or total protein. Conclude that any condition showing darker bands has higher MMP activity and therefore higher invasion potential.\n\nC. Collect conditioned media normalized by volume (not by cell number or total protein) from angiogenic and quiescent cells and perform casein zymography. Include the serine protease inhibitor phenylmethylsulfonyl fluoride (PMSF) during development to test specificity. Report that angiogenic cells show a stronger pro–MMP-9 ($\\sim 92\\,\\mathrm{kDa}$) band, interpret this as increased MMP-9 activity, and conclude that this alone explains the higher invasion seen in angiogenic cells.\n\nD. Analyze only cell lysates by gelatin zymography to detect membrane type 1 MMP (MT1-MMP; also known as MMP-14), and show a prominent band attributed to MT1-MMP. Correlate its intensity with invasion and add tissue inhibitor of metalloproteinases $2$ (TIMP-2) exogenously to increase MMP-2 activation and thereby verify the mechanism. Conclude that the lysate zymography directly measures membrane-bound protease activity driving invasion.\n\nE. Add p-aminophenylmercuric acetate (APMA) during the development step to convert all pro–MMP-2 and pro–MMP-9 to their active forms in the zymogram. Find that after APMA treatment, angiogenic and quiescent samples have similar total gelatinase activity, and infer that activation state (rather than expression) is the sole determinant of invasion. Without performing inhibitor experiments in the invasion assay, conclude that restoring activation would equalize invasion between the two cell states.\n\nSelect the best option.", "solution": "The problem statement is scientifically sound, well-posed, and objective. It provides a clear and accurate background on the molecular biology of matrix metalloproteinases ($MMPs$), the principles of gelatin zymography, and the role of these enzymes in cell invasion. The experimental context, comparing angiogenic versus quiescent endothelial cells, is a standard and relevant model system. The objective is to identify the most rigorous experimental design among the given options to establish a mechanistic link between gelatinase activity and invasion. The statement contains no factual errors, logical contradictions, or ambiguities. We may therefore proceed with the evaluation of the proposed options.\n\nThe core requirements for a scientifically sound design are: $1$) correct normalization to ensure a valid comparison between samples; $2$) proper execution of biochemical assays (zymography) and functional assays (invasion); $3$) inclusion of appropriate positive and negative controls; and $4$) experimental steps that go beyond mere correlation to establish a causal relationship.\n\n**Evaluation of Option A**\n\nThis option presents a comprehensive and rigorous experimental protocol that satisfies all requirements for scientific validity.\n- **Sample Preparation and Normalization**: Conditioned media are collected from equal numbers of cells in serum-free medium. This is correct, as serum itself contains $MMPs$ and their inhibitors ($TIMPs$), which would confound the results. The loading for zymography is further normalized by verifying equal total protein per lane using a bicinchoninic acid ($BCA$) assay. This dual normalization strategy is robust.\n- **Zymography Protocol**: The protocol is executed correctly. Samples are loaded without boiling or reducing agents, which is essential to preserve the enzymatic activity of the proteases. The enzymes are renatured in $2.5\\%$ Triton X-100, and the gel is developed in a buffer containing $Ca^{2+}$ ions ($10\\,\\mathrm{mM}$ calcium chloride), which are required for $MMP$ stability and activity. The absence of chelators in the development buffer is correct.\n- **Controls**: The design includes two critical controls for the zymogram. First, recombinant $MMP-2$ and $MMP-9$ standards are used to unambiguously identify the bands corresponding to the pro- and active forms based on their known molecular weights (pro-$MMP-2 \\sim 72\\,\\mathrm{kDa}$, active $MMP-2 \\sim 62\\,\\mathrm{kDa}$; pro-$MMP-9 \\sim 92\\,\\mathrm{kDa}$, active $MMP-9 \\sim 82\\,\\mathrm{kDa}$). Second, developing lanes in the presence of $5\\,\\mathrm{mM}$ ethylenediaminetetraacetic acid ($EDTA$), a $Zn^{2+}$ chelator, serves as a necessary negative control to confirm that the observed gelatin degradation is indeed mediated by metalloproteinases.\n- **Invasion Assay and Causality**: The Matrigel transwell assay is the standard method for measuring invasion. Crucially, the design does not stop at correlating the observed increase in active $MMP$ levels with increased invasion. It tests for causality using two independent inhibitory strategies: a broad-spectrum metalloproteinase inhibitor ($50\\,\\mu\\mathrm{M}$ 1,10-phenanthroline) and a specific genetic knockdown approach (small interfering $RNA$, or $siRNA$, targeting $MMP-2$). The observation that both interventions suppress invasion provides strong evidence that the increased gelatinase activity is causally responsible for the enhanced invasive phenotype of angiogenic cells.\n- **Conclusion**: The conclusion that \"increased gelatinase activity causally contributes to the elevated invasion of angiogenic endothelial cells\" is fully justified by the experimental evidence presented.\n\nVerdict: **Correct**.\n\n**Evaluation of Option B**\n\nThis option is fundamentally flawed in its understanding and execution of gelatin zymography.\n- **Sample Preparation**: Boiling samples with the reducing agent $\\beta$-mercaptoethanol will irreversibly denature the proteases by disrupting their tertiary structure and reducing disulfide bonds. Such enzymes cannot be renatured in the gel to become active. This procedure is appropriate for standard denaturing $SDS-PAGE$ for protein size analysis, not for zymography which measures enzymatic activity.\n- **Assay Development**: Developing the gel in a buffer containing $10\\,\\mathrm{mM}$ $EDTA$ is incorrect. $EDTA$ is a metalloproteinase inhibitor; it would abolish all gelatinolytic activity. The claim that it \"protects metalloproteinases from autolysis\" is misguided; while autolysis can occur, $EDTA$ functions by inactivating the enzyme entirely.\n- **Quantification and Interpretation**: Zymography detects enzymatic activity as clear bands (zones of substrate degradation) on a stained background. This option incorrectly proposes to quantify \"darker bands,\" which represent undigested protein. Furthermore, the complete lack of normalization for cell number or total protein makes any comparison between samples meaningless.\n\nVerdict: **Incorrect**.\n\n**Evaluation of Option C**\n\nThis option contains multiple errors in experimental design and interpretation.\n- **Normalization**: Normalizing samples by collection volume is inadequate. If a different number of cells contribute to each sample or if their overall protein secretion rate differs, volume-based normalization will lead to artifactual differences. Proper normalization by cell number or total secreted protein is essential.\n- **Assay Specificity**: While casein zymography exists, gelatin zymography is the standard, more specific assay for gelatinases ($MMP-2$ and $MMP-9$), which are the focus of the problem. While including a serine protease inhibitor ($PMSF$) is a reasonable control, the absence of a metalloproteinase inhibitor control ($EDTA$ or 1,10-phenanthroline) is a major omission.\n- **Interpretation**: A critical error lies in interpreting a stronger pro-$MMP-9$ band ($\\sim 92\\,\\mathrm{kDa}$) as \"increased $MMP-9$ activity.\" The pro-form of the enzyme is a latent zymogen. An increase in its level indicates higher expression or secretion, but not necessarily higher enzymatic activity. Biological activity depends on the conversion of the pro-enzyme to its active form ($\\sim 82\\,\\mathrm{kDa}$).\n- **Causality**: The conclusion that this single, misinterpreted observation \"alone explains\" the increased invasion is a gross overstatement. It is a weak correlation that lacks any direct causal evidence from functional inhibitor studies in the invasion assay itself.\n\nVerdict: **Incorrect**.\n\n**Evaluation of Option D**\n\nThis option incorrectly focuses the analysis and misinterprets key biological mechanisms.\n- **Sample Choice**: Analyzing only cell lysates for secreted gelatinases is inappropriate. While cells contain intracellular pools of pro-$MMPs$, the functionally relevant enzymes for degrading an external matrix (like Matrigel) are those that are secreted or active on the cell surface. The major fraction of secreted $MMP-2$ and $MMP-9$ would be in the conditioned medium, which is ignored here.\n- **Assay Target**: Standard gelatin zymography is not the optimal or most specific method to assay membrane-tethered $MT1-MMP$ ($MMP-14$). While $MT1-MMP$ can degrade gelatin, its primary role in this context is the activation of pro-$MMP-2$ at the cell surface. Western blotting of membrane fractions would be a more appropriate method to quantify its expression.\n- **Mechanism Verification**: The proposed use of tissue inhibitor of metalloproteinases 2 ($TIMP-2$) is based on a misunderstanding of its complex role. $TIMP-2$ exhibits biphasic regulation of $MMP-2$ activation. At low concentrations, it can act as an adaptor to facilitate activation by $MT1-MMP$. At higher concentrations, it is a potent inhibitor of both $MT1-MMP$ and active $MMP-2$. Simply adding exogenous $TIMP-2$ \"to increase activation\" is biochemically naive and could easily result in inhibition, invalidating the experiment's premise.\n\nVerdict: **Incorrect**.\n\n**Evaluation of Option E**\n\nThis option performs a valid biochemical manipulation but then fails to complete the logical chain of investigation, leading to an unsupported conclusion.\n- **Assay Manipulation**: The use of $p$-aminophenylmercuric acetate ($APMA$) to chemically activate all pro-$MMPs$ in the gel is a valid technique to measure the total potential gelatinolytic activity (pro-forms plus active forms). The finding that total activity is similar between the two conditions would correctly suggest that regulation occurs at the level of activation, not expression.\n- **Failure to Establish Causality**: The fatal flaw is in the conclusion. The experiment shows a difference in the *in vivo* activation status of the enzyme between the two cell types. However, it then jumps to the conclusion that this activation state is the \"sole determinant of invasion\" *without performing any functional experiments*. To establish this, one must demonstrate in an invasion assay that modulating the activation state alters the invasive capacity. For example, one would need to show that inhibiting upstream activators in angiogenic cells reduces invasion. The option explicitly states that \"inhibitor experiments in the invasion assay\" were not performed. Making a causal claim without such functional evidence is scientifically unacceptable.\n\nVerdict: **Incorrect**.", "answer": "$$\\boxed{A}$$", "id": "2967648"}]}